Maintenance therapy of adult acute nonlymphoblastic leukemia. An argument against the need for central nervous system prophylaxis

James O. Armitage, C. Patrick Burns

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The need for prophylactic therapy of the central nervous system in adult acute nonlymphoblastic leukemia has been suggested but not proven. Over a 4‐year period from January 1973, to December 1976, we have maintained 40 patients achieving complete remission on a regimen consisting of monthly courses of Cytosine Arabinoside and 6‐thioguanine. Twenty patients remain in remission with a predicted median remission duration for the entire group of 14.5 months. Thirty‐nine of the patients did not have central nervous system leukemia at diagnosis, and only one of these patients (2.6%) has had remission terminated by central nervous system relapse. At least with this effective maintenance regimen there is little need for central nervous system prophylaxis in adult acute nonlymphoblastic leukemia.

Original languageEnglish (US)
Pages (from-to)697-700
Number of pages4
JournalCancer
Volume41
Issue number2
DOIs
StatePublished - Feb 1978

Fingerprint

Acute Myeloid Leukemia
Central Nervous System
Cytarabine
Therapeutics
Leukemia
Maintenance
Recurrence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Maintenance therapy of adult acute nonlymphoblastic leukemia. An argument against the need for central nervous system prophylaxis. / Armitage, James O.; Burns, C. Patrick.

In: Cancer, Vol. 41, No. 2, 02.1978, p. 697-700.

Research output: Contribution to journalArticle

@article{cee151bd1c3b40e199db5009c312c00e,
title = "Maintenance therapy of adult acute nonlymphoblastic leukemia. An argument against the need for central nervous system prophylaxis",
abstract = "The need for prophylactic therapy of the central nervous system in adult acute nonlymphoblastic leukemia has been suggested but not proven. Over a 4‐year period from January 1973, to December 1976, we have maintained 40 patients achieving complete remission on a regimen consisting of monthly courses of Cytosine Arabinoside and 6‐thioguanine. Twenty patients remain in remission with a predicted median remission duration for the entire group of 14.5 months. Thirty‐nine of the patients did not have central nervous system leukemia at diagnosis, and only one of these patients (2.6{\%}) has had remission terminated by central nervous system relapse. At least with this effective maintenance regimen there is little need for central nervous system prophylaxis in adult acute nonlymphoblastic leukemia.",
author = "Armitage, {James O.} and Burns, {C. Patrick}",
year = "1978",
month = "2",
doi = "10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M",
language = "English (US)",
volume = "41",
pages = "697--700",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Maintenance therapy of adult acute nonlymphoblastic leukemia. An argument against the need for central nervous system prophylaxis

AU - Armitage, James O.

AU - Burns, C. Patrick

PY - 1978/2

Y1 - 1978/2

N2 - The need for prophylactic therapy of the central nervous system in adult acute nonlymphoblastic leukemia has been suggested but not proven. Over a 4‐year period from January 1973, to December 1976, we have maintained 40 patients achieving complete remission on a regimen consisting of monthly courses of Cytosine Arabinoside and 6‐thioguanine. Twenty patients remain in remission with a predicted median remission duration for the entire group of 14.5 months. Thirty‐nine of the patients did not have central nervous system leukemia at diagnosis, and only one of these patients (2.6%) has had remission terminated by central nervous system relapse. At least with this effective maintenance regimen there is little need for central nervous system prophylaxis in adult acute nonlymphoblastic leukemia.

AB - The need for prophylactic therapy of the central nervous system in adult acute nonlymphoblastic leukemia has been suggested but not proven. Over a 4‐year period from January 1973, to December 1976, we have maintained 40 patients achieving complete remission on a regimen consisting of monthly courses of Cytosine Arabinoside and 6‐thioguanine. Twenty patients remain in remission with a predicted median remission duration for the entire group of 14.5 months. Thirty‐nine of the patients did not have central nervous system leukemia at diagnosis, and only one of these patients (2.6%) has had remission terminated by central nervous system relapse. At least with this effective maintenance regimen there is little need for central nervous system prophylaxis in adult acute nonlymphoblastic leukemia.

UR - http://www.scopus.com/inward/record.url?scp=0017885456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017885456&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

DO - 10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

M3 - Article

C2 - 272947

AN - SCOPUS:0017885456

VL - 41

SP - 697

EP - 700

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -